-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E+7S8TxJZ7U6QW3m2lAAsSOxhHM7nIB5YDwRzirHbWLgrzYVf88Vij38qw1AUdRI vWV63cmOr6YLc4VsL9CRTg== 0000876343-00-000022.txt : 20001214 0000876343-00-000022.hdr.sgml : 20001214 ACCESSION NUMBER: 0000876343-00-000022 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20001213 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-42290 FILM NUMBER: 788260 BUSINESS ADDRESS: STREET 1: 935 PARDEE ST CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108459535 MAIL ADDRESS: STREET 1: 935 PARDEE STREET CITY: BERKELEY STATE: CA ZIP: 94710 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTIME INC CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: 935 PARDEE ST CITY: BERKELEY STATE: CA ZIP: 94710 BUSINESS PHONE: 5108459535 MAIL ADDRESS: STREET 1: 935 PARDEE STREET CITY: BERKELEY STATE: CA ZIP: 94710 SC 13D/A 1 0001.txt 13D - OWNERSHIP REPORTING SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 7)* BioTime, Inc. ............................................................................... (Name of Issuer) Common Shares, no par value ............................................................................... (Title of Class of Securities) 09066L105 ............................................................................... (CUSIP Number) Paul Segall and Judith Segall 935 Pardee Street, Berkeley, California 94710; (510) 845-9535 ............................................................................... (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 8, 2000 ............................................................................... (Date of Event which Requires Filing this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of ss.ss.240.13d-1(e), 240.13d-1(f), or 240.13d-1(g), check the following box [ ]. NOTE: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See ss.240.13d-7(b) for other parties to whom copies are to be sent. *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. CUSIP No. 09066L105 1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above Persons Paul Segall 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] 3) SEC Use Only 4) Source of Funds (See Instructions) PF; OO 5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6) Citizenship or Place of Organization U.S.A. 7) Sole Voting Power Number of 443,245 Shares Beneficially 8) Shared Voting Power Owned by 0 Each Reporting 9) Sole Dispositive Power Person With 443,245 10) Shared Dispositive Power 0 11) Aggregate Amount Beneficially Owned by Each Reporting Person 645,408 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] 13) Percent of Class Represented by Amount in Row (11) 5.7% 14) Type of Reporting Person (See Instructions) IN Page 2 of 4 Pages CUSIP No. 09066L105 1) Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above Persons Judith Segall 2) Check the Appropriate Box if a Member of a Group (See Instructions) (a) [ ] (b) [ ] 3) SEC Use Only 4) Source of Funds (See Instructions) PF; OO 5) Check if Disclosure of Legal Proceedings is Required Pursuant to Items 2(d) or 2(e) [ ] 6) Citizenship or Place of Organization U.S.A. 7) Sole Voting Power Number of 202,163 Shares Beneficially 8) Shared Voting Power Owned by 0 Each Reporting 9) Sole Dispositive Power Person With 202,163 10) Shared Dispositive Power 0 11) Aggregate Amount Beneficially Owned by Each Reporting Person 645,408 12) Check if the Aggregate Amount in Row (11) Excludes Certain Shares (See Instructions) [ ] 13) Percent of Class Represented by Amount in Row (11) 5.7% 14) Type of Reporting Person (See Instructions) IN Page 3 of 4 Pages Item 1. Security and Issuer The class of equity securities to which this schedule relates is Common Shares, no par value (the "Common Shares"), of BioTime, Inc., a California corporation (the "Company"). The Company has its principal executive offices at 935 Pardee Street, Berkeley, California 94710. This schedule is being filed pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act") and the rules and regulations promulgated thereunder. Item 4. Interest in Securities of the Issuer In order to reduce the amount of his margin indebtedness to Donald, Lufkin & Jenrette Securities Corporation, on December 8, 2000 Paul Segall sold 100,000 Common Shares to Alfred D. Kingsley for $3.00 per share, in a privately negotiated transaction. Paul Segall now directly owns 443,245 Common Shares, which constitute approximately 3.9% of the 11,342,786 Common Shares outstanding on December 8, 2000. Judith Segall directly owns 202,163 Common Shares, which constitute approximately 1.8% of the 11,342,786 Common Shares outstanding on December 8, 2000. The Common Shares owned by Mr. and Mrs. Segall in the aggregate constitute approximately 5.7% of the 11,342,786 Common Shares outstanding on December 8, 2000. The forgoing number of outstanding Common Shares is based upon information provided by the Company in its Quarterly Report on Form 10-Q for the period ending September 30, 2000, as filed with the Securities and Exchange Commission. Signature After reasonable inquiry and to the best of our knowledge we certify that the information set forth in the statement is true, complete and correct. /s/Paul Segall Dated: December 12, 2000 ____________________________________ Paul Segall /s/Judith Segall Dated: December 12, 2000 ____________________________________ Judith Segall Page 4 of 4 Pages -----END PRIVACY-ENHANCED MESSAGE-----